The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
1,000 jobs Number of planned job creations
Announcement Date
12 August 2022
Employment effect (start)
Foreseen end date
Description
US healthcare company Abbott Laboratories will create 1,000 new jobs at a new greenfield manufacturing plant in Kilkenny as well as at its existing plant in Donegal. The company plans to invest €440 million in the two plants. The reason behind the expansion and the job creation is to increase production of the 'FreeStyle Libre' technology for people with diabetes. IDA Ireland supports the investment.
The company started its operations in Ireland in 1946 and currently employs 5,000 people at facilities in Donegal, Tipperary, Dublin, Longford, Sligo and Galway.
Previous business expansion was recorded in the ERM database in 2018, with 500 jobs created (Abbott Ireland-2018-IE).
Eurofound (2022), Abbott Ireland, Business expansion in Ireland, factsheet number 107268, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/107268.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
